Knockdown of endothelin A receptor expression inhibits osteosarcoma pulmonary metastasis in an orthotopic xenograft mouse model

Molecular Medicine Reports

Volumn 5, Issue 6, 2012, Pages 1391-1395

  Li, Yong ^a   Liao, Qiande ^a   Li, Kanghua ^a   Zhong, Da ^a   Weng, Xiaojun ^a   Mi, Meng ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Endothelin; Endothelin A receptor; Orthotopic xenograft; Osteosarcoma; Proliferation; Pulmonary metastasis

Indexed keywords

ENDOTHELIN A RECEPTOR; GELATINASE A; SHORT HAIRPIN RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL STRAIN; CONTROLLED STUDY; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LUNG METASTASIS; MOUSE; NONHUMAN; OSTEOSARCOMA; WESTERN BLOTTING; XENOGRAFT;

ANIMALS; BONE NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MATRIX METALLOPROTEINASE 2; MICE; MICE, NUDE; OSTEOSARCOMA; RECEPTOR, ENDOTHELIN A; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSPLANTATION, HETEROLOGOUS;

MUS; MUS MUSCULUS;

EID: 84860769431     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2012.842     Document Type: Article

References (18)

1. Ottaviani G and Jaffe N: The epidemiology of osteosarcoma. Cancer Treat Res 152: 3-13, 2010.
2. Bacci G, Briccoli A, Rocca M, et al: Neoadjuvant chemotherapy for OS of the extremities with metastases at presentation: recent experience at the Rizzoli Institute in 57 patients treated with cisplatin, doxorubicin, and a high dose of methotrexate and ifosfamide. Ann Oncol 14: 1126-1134, 2003. (Pubitemid 36950179)
3. Kager L, Zoubek A, Potschger U, et al: Primary metastatic OS: presentation and outcome of patients treated on neoadjuvant Cooperative OS Study Group protocols. J Clin Oncol 21: 2011-2018, 2003. (Pubitemid 46606391)
4. Ta HT, Dass CR, Choong PF and Dunstan DE: Osteosarcoma treatment: state of the art. Cancer Metastasis Rev 28: 247-263, 2009.
5. Gorlick R, Anderson P, Andrulis I, et al: Biology of childhood osteogenic sarcoma and potential targets for therapeutic development: meeting summary. Clin Cancer Res 9: 5442-5453, 2003. (Pubitemid 37499462)
6. Wittig JC, Bickels J, Priebat D, et al: Osteosarcoma: a multidisciplinary approach to diagnosis and treatment. Am Fam Physician 65: 1123-1132, 2002.
7. Nelson J, Bagnato A, Battistini B and Nisen P: The endothelin axis: emerging role in cancer. Nat Rev Cancer 3: 110-116, 2003. (Pubitemid 37328878)
8. Felx M, Guyot MC, Isler M, Turcotte RE, Doyon J, Khatib AM, Leclerc S, Moreau A and Moldovan F: Endothelin-1 (ET-1) promotes MMP-2 and MMP-9 induction involving the transcription factor NF-kappaB in human osteosarcoma. Clin Sci (Lond) 110: 645-654, 2006. (Pubitemid 43844734)
9. Zhao Y, Liao Q, Zhu Y and Long H: Endothelin-1 promotes osteosarcoma cell invasion and survival against cisplatin-induced apoptosis. Clin Orthop Relat Res 469: 3190-3199, 2011.
10. Yu L, Wang CY, Miao L, Du X, Mayer D and Zhang J: Estrogens promote invasion of prostate cancer cells in a paracrine manner through up-regulation of matrix metalloproteinase 2 in prostatic stromal cells. Endocrinol 152: 773-781, 2011.
11. Dass CR, Ek ET, Contreras KG and Choong PF: A novel orthotopic murine model provides insights into cellular and molecular characteristics contributing to human osteosarcoma. Clin Exp Metastasis 23: 367-380, 2006. (Pubitemid 46197119)
12. Ek ETH, Dass CR, Contreras KG and Choong PFM: Inhibition of orthotopic osteosarcoma growth and metastasis by multitargeted antitumour activities of pigment epithelium-derived factor. Clin Exp Metastasis 24: 93-106, 2007. (Pubitemid 46669247)
13. Pilones KA, Kawashima N, Yang AM, Babb JS, Formenti SC and Demaria S: Invariant natural killer T cells regulate breast cancer response to radiation and CTLA-4 blockade. Clin Cancer Res 15: 597-606, 2009.
14. Sun P, Xiong H, Kim TH, Ren B and Zhang Z: Positive interregulation between beta-catenin/T cell factor-4 signaling and endothelin-1 signaling potentiates proliferation and survival of prostate cancer cells. Mol Pharmacol 69: 520-531, 2006. (Pubitemid 43121949)
15. Sato H and Takino T: Coordinate action of membrane-type matrix metalloproteinase-1 (MT1-MMP) and MMP-2 enhances pericellular proteolysis and invasion. Cancer Sci 101: 843-847, 2010.
16. Bagnato A, Salani D, Di Castro V, et al: Expression of endothelin 1 and endothelin A receptor in ovarian carcinoma: evidence for an autocrine role in tumor growth. Cancer Res 59: 720-727, 1999. (Pubitemid 29076073)
17. Nakamuta M, Ohashi M, Tabata S, et al: High plasma concentrations of endothelin-like immunoreactivities in patients with hepatocellular carcinoma. Am J Gastroenterol 88: 248-252, 1993. (Pubitemid 23053479)
18. Nelson JB, Hedican SP, George DJ, et al: Identification of endothelin- 1 in the pathophysiology of metastatic adenocarcinoma of the prostate. Nat Med 1: 944-949, 1995.